par Ara, M;Gracia-Cazaña, Tamara;Pastushenko, Ievgenia 
Référence Actas dermo-sifiliográficas, 106, 3, page (180-188)
Publication Publié, 2015-04
Référence Actas dermo-sifiliográficas, 106, 3, page (180-188)
Publication Publié, 2015-04
Article révisé par les pairs
| Résumé : | Biologic drugs have provided excellent results in the treatment of moderate to severe psoriasis. Nevertheless, in routine clinical practice, combinations of biologic drugs with phototherapy or systemic drugs can increase efficacy, diminish toxicity, and reduce the cost of treatment. Published experience with these combinations is scarce, although the results are often satisfactory. This review examines the most relevant published experience in the combination of the most studied drug in this field-etanercept-with methotrexate, acitretin, ciclosporin, and narrowband UV-B phototherapy. Findings reported in the literature can help when taking major decisions on the management of biologic and systemic drugs in moderate to severe psoriasis. |
